Back to search

University of British Columbia

A quantitative assessment of access to medicines in Canada using administrative and survey data

Abstract

dc:description

Background: Prescription medicines are an important component of outpatient healthcare in Canada and account for 13.6% of total health expenditures. However, access to medicines is unequal. Despite current gaps in coverage, there is of lack information on which groups cannot afford prescription medicines and the potential impacts of expanding drug coverage on medicine access. This thesis provides novel empiric contributions to both of these knowledge areas. Methods: This thesis includes two studies of medicine access in Canada. The first used Latent Class Analysis (LCA) to identify subgroups in the population of Canadians that experienced cost-related nonadherence (CRNA) to prescription medicines. With data from the Canadian Community Health Survey, LCA was used to characterize and identify predictors of membership in different subgroups. The second study used a controlled interrupted time-series study design to examine the impact of a 2019 policy that eliminated all copayment requirements for the lowest income patients in the British Columbia (BC) Fair PharmaCare program. Using population-level administrative data, I studied the impact of the change on prescription drug use and expenditures. Additionally, I conducted a pre-post analysis to examine if the impacts of this policy were broad-based or concentrated amongst specific drug classes. Results: We identified four subgroups in the population of Canadians that experienced CRNA. There are significant differences in the profiles of patients across latent classes, and 73% of patient who report CRNA belong to subgroups characterized by higher incomes and prevalent insurance coverage. The copayment elimination policy in BC led to a 16% rise in monthly prescription drug expenditures and a 13% increase in the mean number of prescriptions dispensed for the target population, after accounting for changes in the control group. We observed increases in expenditures and dispensing across most therapeutic classes with the elimination of copayments. Conclusion: While financial constraints and insurance coverage are important determinants of CRNA, this phenomenon is not confined solely to low-income and uninsured patients. Nonetheless, the elimination of copayments for low-income households in BC led to improvements in prescription drug access and may represent a model policy for advancing access to medicines for low-income Canadians.

Degree

thesis:*
Name thesis:degree_name
Master of Science - MSc
Level thesis:degree_level
master's
Discipline thesis:degree_discipline
Population and Public Health
Grantor dc:publisher
University of British Columbia
Year dc:date
2023

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Sharma, Kartik
Contributors dc:contributor
  • Law, Michael R.

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/86198

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Sharma, Kartik. A quantitative assessment of access to medicines in Canada using administrative and survey data. master's thesis, University of British Columbia, 2023. http://hdl.handle.net/2429/86198